(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 231301 - BBL Sensi-Disc Kanamycin K-30, 30mcg Precision AST Disc for Aminoglycoside Susceptibility Testing, 10/PK

BD  # 231301 - BBL Sensi-Disc Kanamycin K-30, 30mcg  Precision AST Disc for Aminoglycoside Susceptibility Testing,  10/PK
Part Number BD 231301
SKU Number CIA1127879
Sell Unit PACK
Ships Within Special Order
List Price $162.27
Enter a valid quantity
Product Description

BD 231301 - BBL Sensi-Disc Kanamycin K-30, 30mcg Precision AST Disc for Aminoglycoside Susceptibility Testing, 10/PK

The BD 231301 BBL Sensi-Disc Kanamycin K-30 (30mcg) is a high-quality antimicrobial susceptibility testing (AST) disc designed for accurate evaluation of bacterial response to kanamycin, an aminoglycoside antibiotic widely used in clinical and research microbiology. Each sterile disc contains 30 micrograms of kanamycin and is engineered for standardized diffusion on Mueller-Hinton agar, ensuring reliable and reproducible inhibition zones using the Kirby-Bauer disk diffusion method. BDs consistent manufacturing quality ensures dependable potency and clear, interpretable zone morphology.

Key Benefits

This Sensi-Disc provides sharp, well-defined inhibition zones, supporting precise susceptibility interpretation for a wide range of organisms. The sterile, single-use format minimizes contamination and maintains consistent antibiotic delivery. BDs tight quality control ensures lot-to-lot uniformity, making the disc ideal for routine diagnostics, surveillance programs, and research applications where accuracy is essential.

Compatibility and Applications

The BD 231301 Kanamycin K-30 disc is fully compatible with standard Mueller-Hinton agar used for disk diffusion AST. It is widely used to evaluate susceptibility in:

  • Enterobacterales
  • Pseudomonas species
  • Staphylococcus and other Gram-positive organisms, depending on testing guidelines
  • Aminoglycoside-resistant strain screening

It also plays an important role in:

  • Routine clinical AST panels
  • Antibiotic resistance trend monitoring
  • Teaching laboratories performing aminoglycoside diffusion testing
  • Research focused on protein-synthesisinhibiting antibiotics

Usage Guidelines

Prepare a standardized bacterial suspension (0.5 McFarland) and inoculate Mueller-Hinton agar uniformly. Apply the BD 231301 disc using sterile forceps or a disc dispenser. Incubate plates at 3537C for 1620 hours. Measure inhibition zones and interpret kanamycin susceptibility according to current CLSI or EUCAST guidelines. Store discs at 28C in moisture-protected containers with desiccants.

Certifications, Safety Standards, and Regulatory Approvals

The BD 231301 Sensi-Disc is manufactured under ISO 9001 and ISO 13485 certified quality systems. It meets FDA and CE regulatory requirements for in vitro diagnostic (IVD) materials. Each lot is evaluated for antibiotic content, diffusion uniformity, sterility, and long-term stability to ensure consistent AST performance.

Comparison with Competitor Products

Compared to generic kanamycin discs, BD Sensi-Discs offer superior potency stability, cleaner diffusion patterns, and clear zone edges critical for accurate reading. Competitor brands may show inconsistent antibiotic loading or susceptibility to moisture degradation. BDs robust packaging and manufacturing precision ensure dependable results in high-volume diagnostic laboratories.

Typical User Profile and Application Scenarios

This product is used by:

  • Clinical microbiologists in hospital and reference laboratories
  • Infectious-disease diagnostic teams
  • Public health surveillance programs monitoring aminoglycoside resistance
  • Academic and research institutions teaching AST techniques

Best Practices for Use and Maintenance

Avoid moisture exposure by opening disc containers only when ready to test. Allow refrigerated discs to reach room temperature before opening to prevent condensation. Handle with sterile forceps and avoid touching the antibiotic-containing surface. Use established QC strains such as E. coli ATCC 25922 to verify performance. Discard expired or compromised discs.

Regulatory and Safety Information

The BD 231301 Kanamycin K-30 Sensi-Disc is intended for in vitro diagnostic use by trained laboratory personnel. Follow biosafety level 2 guidelines for handling clinical isolates. Wear appropriate PPE and dispose of used discs and plates as regulated biohazard waste.

How to Order

To order the BD 231301 BBL Sensi-Disc Kanamycin K-30 (30mcg), add the product to your cart and complete checkout through CIA Medicals secure system. For bulk quantities, supply agreements, or technical support, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry using the contact form on this page. Our team is available to assist with availability, pricing, and documentation.